NCT00300027View on ClinicalTrials.gov

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

PHASE1TerminatedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2006

Conditions
Gastrointestinal Neoplasms
Interventions
DRUG

BMS-582664

Trial Locations (6)

Unknown

Local Institution, Little Rock

Local Institution, Los Angeles

Local Institution, Washington D.C.

Local Institution, Iowa City

Local Institution, Durham

Local Institution, Temple

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY